The Summit will bring together patients, providers, policy-makers, industry, payers, government, and other stakeholders for an in-depth discussion about biosimilars and molecular testing, review the newest guidance documents and regulatory requirements, examine payer viewpoints and practices, and discuss the future of these important topics.